Nirrin Technologies received U.S. Patent 12,222,279 B2 for its advanced flow-cell technology for in-bioprocess analytics. This patent expands Nirrin’s capabilities in real-time process monitoring, offering greater precision, flexibility, and efficiency to bioprocessing workflows, according to the company.
“This innovation represents an exciting leap forward for real-time bioprocess monitoring tools,” said Bryan Hassell, PhD, CTO at Nirrin Technologies. “By addressing key challenges in optical fluid analysis, we are empowering biopharmaceutical manufacturers with the tools to enhance efficiency, ensure consistency, and advance Biopharma 4.0 with smarter, data-driven insights for confident decisions.”
By integrating active temperature regulation, precise optical path control, and a versatile form factor, this newly patented innovation elevates real-time bioprocess monitoring, continued Hassell, adding that it enables more consistent, high-quality data to support better decision-making and process optimization.